☰

Julio A. Lamprea-Montealegre, Ph.D. - Publications

Affiliations: 
2012 Johns Hopkins University, Baltimore, MD 
Area:
Epidemiology
Tree Info Similar researchers PubMed Report error

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Lamprea-Montealegre JA. Unlocking the potential: boosting SGLT2 inhibitor uptake to prevent the cardiorenal consequences of chronic kidney disease. The Lancet Regional Health. Western Pacific. 43: 101004. PMID 38292307 DOI: 10.1016/j.lanwpc.2023.101004  0.365
2023 Chu CD, Xia F, Du Y, Singh R, Tuot DS, Lamprea-Montealegre JA, Gualtieri R, Liao N, Kong SX, Williamson T, Shlipak MG, Estrella MM. Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease. Jama Network Open. 6: e2326230. PMID 37498594 DOI: 10.1001/jamanetworkopen.2023.26230  0.451
2022 Lamprea-Montealegre JA, Madden E, Tummalapalli SL, Chu CD, Peralta CA, Du Y, Singh R, Kong SX, Tuot DS, Shlipak MG, Estrella MM. Prescription Patterns of Cardiovascular- and Kidney-Protective Therapies Among Patients With Type 2 Diabetes and Chronic Kidney Disease. Diabetes Care. PMID 36156061 DOI: 10.2337/dc22-0614  0.32
2022 Lamprea-Montealegre JA, Madden E, Tummalapalli SL, Peralta C, Neilands TB, Garcia PK, Muiru A, Karliner L, Shlipak MG, Estrella MM. Association of Race and Ethnicity With Prescription of SGLT2 Inhibitors and GLP1 Receptor Agonists Among Patients With Type 2 Diabetes in the Veterans Health Administration System. Jama. 328: 861-871. PMID 36066519 DOI: 10.1001/jama.2022.13885  0.317
2021 Lamprea-Montealegre JA, Katz R, Scharnagl H, Silbernagel G, März W, Drechsler C, Wanner C, de Boer IH. Triglyceride-Rich Lipoproteins, Apolipoproteins, and Atherosclerotic Cardiovascular Events Among Patients with Diabetes Mellitus and End-Stage Renal Disease on Hemodialysis. The American Journal of Cardiology. PMID 34108090 DOI: 10.1016/j.amjcard.2021.04.023  0.358
2021 Lamprea-Montealegre JA, Shlipak MG, Estrella MM. Chronic kidney disease detection, staging and treatment in cardiovascular disease prevention. Heart (British Cardiac Society). 107: 1282-1288. PMID 33568433 DOI: 10.1136/heartjnl-2020-318004  0.439
2019 Lamprea-Montealegre JA, Staplin N, Herrington WG, Haynes R, Emberson J, Baigent C, de Boer IH. Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 31831577 DOI: 10.2215/Cjn.07320619  0.459
2019 Lamprea-Montealegre JA, McClelland RL, Otvos JD, Mora S, Koch M, Jensen MK, de Boer IH. Association of High-Density Lipoprotein Particles and High-Density Lipoprotein Apolipoprotein C-III Content With Cardiovascular Disease Risk According to Kidney Function: The Multi-Ethnic Study of Atherosclerosis. Journal of the American Heart Association. 8: e013713. PMID 31818211 DOI: 10.1161/Jaha.119.013713  0.407
2019 Lamprea-Montealegre JA, Zelnick LR, Shlipak MG, Floyd JS, Anderson AH, He J, Christenson R, Seliger SL, Soliman EZ, Deo R, Ky B, Feldman HI, Kusek JW, deFilippi CR, Wolf MS, et al. Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study. Journal of the American Heart Association. 8: e012200. PMID 31379242 DOI: 10.1161/Jaha.119.012200  0.38
2018 Lamprea-Montealegre JA, Zelnick LR, Hall YN, Bansal N, de Boer IH. Prevalence of Hypertension and Cardiovascular Risk According to Blood Pressure Thresholds Used for Diagnosis. Hypertension (Dallas, Tex. : 1979). 72: 602-609. PMID 30354757 DOI: 10.1161/Hypertensionaha.118.11609  0.377
2018 Lamprea-Montealegre JA, de Boer IH. Reevaluating the Evidence for Blood Pressure Targets in Type 2 Diabetes. Diabetes Care. 41: 1132-1133. PMID 29784697 DOI: 10.2337/Dci17-0063  0.316
2018 Lamprea-Montealegre JA, McClelland RL, Grams M, Ouyang P, Szklo M, de Boer IH. Coronary heart disease risk associated with the dyslipidaemia of chronic kidney disease. Heart (British Cardiac Society). PMID 29472290 DOI: 10.1136/Heartjnl-2017-312794  0.578
2014 Lamprea-Montealegre JA, Sharrett AR, Matsushita K, Selvin E, Szklo M, Astor BC. Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: the ARIC study. Atherosclerosis. 234: 42-6. PMID 24607852 DOI: 10.1016/J.Atherosclerosis.2014.02.006  0.594
2013 Lamprea-Montealegre JA, McClelland RL, Astor BC, Matsushita K, Shlipak M, de Boer IH, Szklo M. Chronic kidney disease, plasma lipoproteins, and coronary artery calcium incidence: the Multi-Ethnic Study of Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 33: 652-8. PMID 23329135 DOI: 10.1161/Atvbaha.112.300624  0.558
2012 Lamprea-Montealegre JA, Astor BC, McClelland RL, de Boer IH, Burke GL, Sibley CT, O'Leary D, Sharrett AR, Szklo M. CKD, plasma lipids, and common carotid intima-media thickness: results from the multi-ethnic study of atherosclerosis. Clinical Journal of the American Society of Nephrology : Cjasn. 7: 1777-85. PMID 22879436 DOI: 10.2215/Cjn.02090212  0.483
Show low-probability matches.